These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 32691156)

  • 21. Serum ciliary neurotrophic factor levels in children with attention deficit hyperactivity disorder.
    Buyuktaskin D; Guney E; Gulbahar O; Ozaslan A; Arslan B
    Int J Neurosci; 2024 Apr; 134(4):313-317. PubMed ID: 35815398
    [No Abstract]   [Full Text] [Related]  

  • 22. The Behavior Rating Inventory of Executive Function and Continuous Performance Test in Preschoolers with Attention Deficit Hyperactivity Disorder.
    Çak HT; Çengel Kültür SE; Gökler B; Öktem F; Taşkıran C
    Psychiatry Investig; 2017 May; 14(3):260-270. PubMed ID: 28539944
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Parent-reported sleep problems, symptom ratings, and serum ferritin levels in children with attention-deficit/hyperactivity disorder: a case control study.
    Abou-Khadra MK; Amin OR; Shaker OG; Rabah TM
    BMC Pediatr; 2013 Dec; 13():217. PubMed ID: 24377840
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Are autism spectrum disorder and attention-deficit/hyperactivity disorder different manifestations of one overarching disorder? Cognitive and symptom evidence from a clinical and population-based sample.
    van der Meer JM; Oerlemans AM; van Steijn DJ; Lappenschaar MG; de Sonneville LM; Buitelaar JK; Rommelse NN
    J Am Acad Child Adolesc Psychiatry; 2012 Nov; 51(11):1160-1172.e3. PubMed ID: 23101742
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vitamin D deficiency in school-age Iranian children with attention-deficit/hyperactivity disorder (ADHD) symptoms: A critical comparison with healthy controls.
    Fasihpour B; Moayeri H; Shariat M; Keihanidoust Z; Effatpanah M; Khedmat L
    Child Neuropsychol; 2020 May; 26(4):460-474. PubMed ID: 31514566
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Candidate genetic pathways for attention-deficit/hyperactivity disorder (ADHD) show association to hyperactive/impulsive symptoms in children with ADHD.
    Bralten J; Franke B; Waldman I; Rommelse N; Hartman C; Asherson P; Banaschewski T; Ebstein RP; Gill M; Miranda A; Oades RD; Roeyers H; Rothenberger A; Sergeant JA; Oosterlaan J; Sonuga-Barke E; Steinhausen HC; Faraone SV; Buitelaar JK; Arias-Vásquez A
    J Am Acad Child Adolesc Psychiatry; 2013 Nov; 52(11):1204-1212.e1. PubMed ID: 24157394
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Groundskeeper Gaming Platform as a Diagnostic Tool for Attention-Deficit/Hyperactivity Disorder: Sensitivity, Specificity, and Relation to Other Measures.
    Faraone SV; Newcorn JH; Antshel KM; Adler L; Roots K; Heller M
    J Child Adolesc Psychopharmacol; 2016 Oct; 26(8):672-685. PubMed ID: 27105181
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum Interleukin-6 Level in Children With Attention-Deficit Hyperactivity Disorder (ADHD).
    Darwish AH; Elgohary TM; Nosair NA
    J Child Neurol; 2019 Feb; 34(2):61-67. PubMed ID: 30430896
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High Attention-Deficit/Hyperactivity Disorder Scale Scores Among Patients with Persistent Chronic Nonspecific Low Back Pain.
    Kasahara S; Niwa SI; Matsudaira K; Sato N; Oka H; Fujii T; Konno SI; Kikuchi SI; Yamada Y
    Pain Physician; 2021 May; 24(3):E299-E307. PubMed ID: 33988951
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of vitamin D supplementation as adjunctive therapy to methylphenidate on ADHD symptoms: A randomized, double blind, placebo-controlled trial.
    Mohammadpour N; Jazayeri S; Tehrani-Doost M; Djalali M; Hosseini M; Effatpanah M; Davari-Ashtiani R; Karami E
    Nutr Neurosci; 2018 Apr; 21(3):202-209. PubMed ID: 27924679
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Maternal Mild Thyroid Hormone Insufficiency in Early Pregnancy and Attention-Deficit/Hyperactivity Disorder Symptoms in Children.
    Modesto T; Tiemeier H; Peeters RP; Jaddoe VW; Hofman A; Verhulst FC; Ghassabian A
    JAMA Pediatr; 2015 Sep; 169(9):838-45. PubMed ID: 26146876
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of guanfacine extended release on oppositional symptoms in children aged 6-12 years with attention-deficit hyperactivity disorder and oppositional symptoms: a randomized, double-blind, placebo-controlled trial.
    Connor DF; Findling RL; Kollins SH; Sallee F; López FA; Lyne A; Tremblay G
    CNS Drugs; 2010 Sep; 24(9):755-68. PubMed ID: 20806988
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Atomoxetine improved attention in children and adolescents with attention-deficit/hyperactivity disorder and dyslexia in a 16 week, acute, randomized, double-blind trial.
    Wietecha L; Williams D; Shaywitz S; Shaywitz B; Hooper SR; Wigal SB; Dunn D; McBurnett K
    J Child Adolesc Psychopharmacol; 2013 Nov; 23(9):605-13. PubMed ID: 24206099
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relationship between anxiety, anxiety sensitivity and conduct disorder symptoms in children and adolescents with attention-deficit/hyperactivity disorder (ADHD).
    Bilgiç A; Türkoğlu S; Ozcan O; Tufan AE; Yılmaz S; Yüksel T
    Eur Child Adolesc Psychiatry; 2013 Sep; 22(9):523-32. PubMed ID: 23460041
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The efficacy and safety profile of lisdexamfetamine dimesylate, a prodrug of d-amphetamine, for the treatment of attention-deficit/hyperactivity disorder in children and adults.
    Najib J
    Clin Ther; 2009 Jan; 31(1):142-76. PubMed ID: 19243715
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High pretreatment cognitive impulsivity predicts response of oppositional symptoms to methylphenidate in patients with attention-deficit hyperactivity disorder/oppositional defiant disorder.
    Golubchik P; Shalev L; Tsamir D; Manor I; Weizman A
    Int Clin Psychopharmacol; 2019 May; 34(3):138-142. PubMed ID: 30640748
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Familial clustering of symptoms and disruptive behaviors in multiplex families with attention-deficit/hyperactivity disorder.
    Smalley SL; McGough JJ; Del'Homme M; NewDelman J; Gordon E; Kim T; Liu A; McCracken JT
    J Am Acad Child Adolesc Psychiatry; 2000 Sep; 39(9):1135-43. PubMed ID: 10986810
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ADHD symptoms, breast-feeding and obesity in children and adolescents.
    Türkoğlu S; Bilgiç A; Akça ÖF
    Pediatr Int; 2015 Aug; 57(4):546-51. PubMed ID: 25625700
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Validation of the Turkish versions of the short-form Conners' teacher and parent rating scales].
    Dereboy C; Senol S; Sener S; Dereboy F
    Turk Psikiyatri Derg; 2007; 18(1):48-58. PubMed ID: 17364268
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical features and subjective/physiological responses to emotional stimuli in the presence of emotion dysregulation in attention-deficit hyperactivity disorder.
    Taskiran C; Karaismailoglu S; Cak Esen HT; Tuzun Z; Erdem A; Balkanci ZD; Dolgun AB; Cengel Kultur SE
    J Clin Exp Neuropsychol; 2018 May; 40(4):389-404. PubMed ID: 28721740
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.